Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1991 2
1992 1
1993 3
1994 4
1995 2
1996 3
1997 3
1998 2
2000 2
2002 3
2003 3
2004 4
2005 3
2007 1
2008 1
2009 3
2010 2
2011 2
2012 4
2013 12
2014 13
2015 13
2016 9
2017 7
2018 6
2019 6
2020 9
2021 14
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: yane k. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
[Imaging diagnosis for pancreaticobiliary maljunction].
Maguchi H, Osanai M, Katanuma A, Yane K, Takahashi K. Maguchi H, et al. Among authors: yane k. Nihon Shokakibyo Gakkai Zasshi. 2014 Apr;111(4):690-8. Nihon Shokakibyo Gakkai Zasshi. 2014. PMID: 24769457 Review. Japanese. No abstract available.
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. Higashiyama T, et al. Among authors: yane k. Eur J Cancer. 2022 Sep;173:210-218. doi: 10.1016/j.ejca.2022.06.044. Epub 2022 Aug 3. Eur J Cancer. 2022. PMID: 35932627 Clinical Trial.
[Current advancement of balloon-enteroscopy-assisted ERCP].
Katanuma A, Maguchi H, Yane K, Kin T, Ikarashi S, Yamazaki H, Kitagawa K, Koga H, Yokoyama K, Sano I, Nagai K, Takahashi K. Katanuma A, et al. Among authors: yane k. Nihon Shokakibyo Gakkai Zasshi. 2016 Apr;113(4):603-13. doi: 10.11405/nisshoshi.113.603. Nihon Shokakibyo Gakkai Zasshi. 2016. PMID: 27052390 Review. Japanese. No abstract available.
136 results